|
GB9801098D0
|
|
Anti-viral agents
|
|
GB9701117D0
|
|
HIV Treatment
|
|
GB9708380D0
|
|
HIV treatment
|
|
GB9615619D0
|
|
Costimulation of TcR/CD3-induced T-Lymphocytes
|
|
AU5115396A
|
|
Anti-viral and anti-cancer agents
|
|
GB9505468D0
|
|
Benzoic acid containing chloro and or nitro groups for cancer or viral therapy
|
|
ZA9502191B
|
|
Anti-viral and anti cancer agents
|
|
GB9804302D0
|
|
Anti-viral agents
|
|
GB9410420D0
|
|
Substances for use in treatment of HIV-infection in HIV-infected patients
|
|
AP9400647A0
|
|
Medicaments for use in treatment of HIV or cancer patients.
|
|
GB9321558D0
|
|
Anti-viral agents
|
|
GB9310520D0
|
|
Arylating agents
|
|
LV10385A
|
|
Use of quinons in the treatment of cancer or aids
|
|
LTIP170A
|
|
Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
|
|
OA09676A
|
|
Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
|
|
HRP920891A2
|
|
Quinone preparation
|
|
JO1708B1
|
|
Use of trinitrobenzenes or carminec acid in the treatment of cancer or viral diseses
|
|
IL100906D0
|
|
Pharmaceutical compositions comprising carminic acid and optionally one or more quinones
|
|
EP0524212A1
|
|
Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
|
